Johnson & Johnson (JNJ)
BMV
Closed
Aug 21, 2026
Day's Range
4,584.0052 wk Range
3,200.01Overview - JNJ - Johnson & Johnson
Key Statistics
Valuation
Enterprise Value
187.29T
P/E (Trailing)
‪31.44‬
PEG Ratio
‪-275.07‬
Price / Sales (TTM)
‪112.90‬
Price / Book
‪7.63‬
EV / EBITDA
‪317.87‬
Profitability
Gross Margin
‪68.19%‬
Profit Margin
‪21.48%‬
Operating Margin
‪29.19%‬
Return on Assets
‪8.59%‬
Return on Equity
‪25.74%‬
Ownership
Shares Outstanding
2.40B
Float
2.40B
Held by Insiders
‪0.05%‬
Held by Institutions
‪76.90%‬
Price stats
Beta
‪0.23‬
50-Day Avg
‪4,415.95‬
200-Day Avg
‪4,084.88‬
Dividends
Payout Ratio
‪60.79%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - JNJ - Johnson & Johnson
Peers - JNJ - Johnson & Johnson
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BMV.
- JNJBMVJohnson & Johnson11.14TMarket Cap+26.65%52-week change31.53P/E (Trailing)‪21.48%‬Profit Margin
- ABBVBMVAbbVie Inc.7.94TMarket Cap+13.73%52-week change75.19P/E (Trailing)‪9.80%‬Profit Margin
- MRKBMVMerck & Co., Inc.6.36TMarket Cap+36.51%52-week change108.64P/E (Trailing)‪4.76%‬Profit Margin
- ROP1NBMVRoche Holding AG6.05TMarket Cap+1.57%52-week change23.58P/E (Trailing)‪19.60%‬Profit Margin
- NVNVSNBMVNovartis AG Sponsored ADR5.08TMarket Cap+17.59%52-week change23.70P/E (Trailing)‪22.50%‬Profit Margin
- NOVNNBMVNovartis AG4.94TMarket Cap+13.16%52-week change23.09P/E (Trailing)‪22.50%‬Profit Margin
- AZN1NBMVAstraZeneca PLC4.21TMarket Cap-9.68%52-week change23.87P/E (Trailing)‪17.02%‬Profit Margin
Profile Summary - JNJ - Johnson & Johnson
About
Johnson & Johnson is a holding company engaged in the research, development, manufacture, and sale of healthcare products worldwide. It operates through two primary segments: Innovative Medicine, which focuses on pharmaceuticals including treatments for immunology, oncology, infectious diseases, neuroscience,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
